Global Hepatitis B Vaccines Market Insights and Forecast to 2028

Report ID: 1241717 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Hepatitis B Vaccines Product Introduction
    1.2 Market by Type
        1.2.1 Global Hepatitis B Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Yeast Derived
        1.2.3 CHO Derived
    1.3 Market by Application
        1.3.1 Global Hepatitis B Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Children
        1.3.3 Adult
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Hepatitis B Vaccines Sales Estimates and Forecasts 2017-2028
    2.2 Global Hepatitis B Vaccines Revenue Estimates and Forecasts 2017-2028
    2.3 Global Hepatitis B Vaccines Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Hepatitis B Vaccines Sales by Region
        2.4.1 Global Hepatitis B Vaccines Sales by Region (2017-2022)
        2.4.2 Global Sales Hepatitis B Vaccines by Region (2023-2028)
    2.5 Global Hepatitis B Vaccines Revenue by Region
        2.5.1 Global Hepatitis B Vaccines Revenue by Region (2017-2022)
        2.5.2 Global Hepatitis B Vaccines Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Hepatitis B Vaccines Sales by Manufacturers
        3.1.1 Global Top Hepatitis B Vaccines Manufacturers by Sales (2017-2022)
        3.1.2 Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hepatitis B Vaccines in 2021
    3.2 Global Hepatitis B Vaccines Revenue by Manufacturers
        3.2.1 Global Hepatitis B Vaccines Revenue by Manufacturers (2017-2022)
        3.2.2 Global Hepatitis B Vaccines Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Hepatitis B Vaccines Revenue in 2021
    3.3 Global Hepatitis B Vaccines Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Hepatitis B Vaccines Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Hepatitis B Vaccines Sales by Type
        4.1.1 Global Hepatitis B Vaccines Historical Sales by Type (2017-2022)
        4.1.2 Global Hepatitis B Vaccines Forecasted Sales by Type (2023-2028)
        4.1.3 Global Hepatitis B Vaccines Sales Market Share by Type (2017-2028)
    4.2 Global Hepatitis B Vaccines Revenue by Type
        4.2.1 Global Hepatitis B Vaccines Historical Revenue by Type (2017-2022)
        4.2.2 Global Hepatitis B Vaccines Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Hepatitis B Vaccines Revenue Market Share by Type (2017-2028)
    4.3 Global Hepatitis B Vaccines Price by Type
        4.3.1 Global Hepatitis B Vaccines Price by Type (2017-2022)
        4.3.2 Global Hepatitis B Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Hepatitis B Vaccines Sales by Application
        5.1.1 Global Hepatitis B Vaccines Historical Sales by Application (2017-2022)
        5.1.2 Global Hepatitis B Vaccines Forecasted Sales by Application (2023-2028)
        5.1.3 Global Hepatitis B Vaccines Sales Market Share by Application (2017-2028)
    5.2 Global Hepatitis B Vaccines Revenue by Application
        5.2.1 Global Hepatitis B Vaccines Historical Revenue by Application (2017-2022)
        5.2.2 Global Hepatitis B Vaccines Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Hepatitis B Vaccines Revenue Market Share by Application (2017-2028)
    5.3 Global Hepatitis B Vaccines Price by Application
        5.3.1 Global Hepatitis B Vaccines Price by Application (2017-2022)
        5.3.2 Global Hepatitis B Vaccines Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Hepatitis B Vaccines Market Size by Type
        6.1.1 North America Hepatitis B Vaccines Sales by Type (2017-2028)
        6.1.2 North America Hepatitis B Vaccines Revenue by Type (2017-2028)
    6.2 North America Hepatitis B Vaccines Market Size by Application
        6.2.1 North America Hepatitis B Vaccines Sales by Application (2017-2028)
        6.2.2 North America Hepatitis B Vaccines Revenue by Application (2017-2028)
    6.3 North America Hepatitis B Vaccines Market Size by Country
        6.3.1 North America Hepatitis B Vaccines Sales by Country (2017-2028)
        6.3.2 North America Hepatitis B Vaccines Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Hepatitis B Vaccines Market Size by Type
        7.1.1 Europe Hepatitis B Vaccines Sales by Type (2017-2028)
        7.1.2 Europe Hepatitis B Vaccines Revenue by Type (2017-2028)
    7.2 Europe Hepatitis B Vaccines Market Size by Application
        7.2.1 Europe Hepatitis B Vaccines Sales by Application (2017-2028)
        7.2.2 Europe Hepatitis B Vaccines Revenue by Application (2017-2028)
    7.3 Europe Hepatitis B Vaccines Market Size by Country
        7.3.1 Europe Hepatitis B Vaccines Sales by Country (2017-2028)
        7.3.2 Europe Hepatitis B Vaccines Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Hepatitis B Vaccines Market Size by Type
        8.1.1 Asia Pacific Hepatitis B Vaccines Sales by Type (2017-2028)
        8.1.2 Asia Pacific Hepatitis B Vaccines Revenue by Type (2017-2028)
    8.2 Asia Pacific Hepatitis B Vaccines Market Size by Application
        8.2.1 Asia Pacific Hepatitis B Vaccines Sales by Application (2017-2028)
        8.2.2 Asia Pacific Hepatitis B Vaccines Revenue by Application (2017-2028)
    8.3 Asia Pacific Hepatitis B Vaccines Market Size by Region
        8.3.1 Asia Pacific Hepatitis B Vaccines Sales by Region (2017-2028)
        8.3.2 Asia Pacific Hepatitis B Vaccines Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Hepatitis B Vaccines Market Size by Type
        9.1.1 Latin America Hepatitis B Vaccines Sales by Type (2017-2028)
        9.1.2 Latin America Hepatitis B Vaccines Revenue by Type (2017-2028)
    9.2 Latin America Hepatitis B Vaccines Market Size by Application
        9.2.1 Latin America Hepatitis B Vaccines Sales by Application (2017-2028)
        9.2.2 Latin America Hepatitis B Vaccines Revenue by Application (2017-2028)
    9.3 Latin America Hepatitis B Vaccines Market Size by Country
        9.3.1 Latin America Hepatitis B Vaccines Sales by Country (2017-2028)
        9.3.2 Latin America Hepatitis B Vaccines Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Hepatitis B Vaccines Market Size by Type
        10.1.1 Middle East and Africa Hepatitis B Vaccines Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Hepatitis B Vaccines Revenue by Type (2017-2028)
    10.2 Middle East and Africa Hepatitis B Vaccines Market Size by Application
        10.2.1 Middle East and Africa Hepatitis B Vaccines Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Hepatitis B Vaccines Revenue by Application (2017-2028)
    10.3 Middle East and Africa Hepatitis B Vaccines Market Size by Country
        10.3.1 Middle East and Africa Hepatitis B Vaccines Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Hepatitis B Vaccines Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 GSK
        11.1.1 GSK Corporation Information
        11.1.2 GSK Overview
        11.1.3 GSK Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 GSK Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 GSK Recent Developments
    11.2 NCPC
        11.2.1 NCPC Corporation Information
        11.2.2 NCPC Overview
        11.2.3 NCPC Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 NCPC Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 NCPC Recent Developments
    11.3 Merck
        11.3.1 Merck Corporation Information
        11.3.2 Merck Overview
        11.3.3 Merck Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Merck Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Merck Recent Developments
    11.4 Bio Kangtai
        11.4.1 Bio Kangtai Corporation Information
        11.4.2 Bio Kangtai Overview
        11.4.3 Bio Kangtai Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Bio Kangtai Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Bio Kangtai Recent Developments
    11.5 Dynavax
        11.5.1 Dynavax Corporation Information
        11.5.2 Dynavax Overview
        11.5.3 Dynavax Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Dynavax Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Dynavax Recent Developments
    11.6 Hissen
        11.6.1 Hissen Corporation Information
        11.6.2 Hissen Overview
        11.6.3 Hissen Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Hissen Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Hissen Recent Developments
    11.7 KM Biologics
        11.7.1 KM Biologics Corporation Information
        11.7.2 KM Biologics Overview
        11.7.3 KM Biologics Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 KM Biologics Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 KM Biologics Recent Developments
    11.8 LG Life Sciences
        11.8.1 LG Life Sciences Corporation Information
        11.8.2 LG Life Sciences Overview
        11.8.3 LG Life Sciences Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 LG Life Sciences Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 LG Life Sciences Recent Developments
    11.9 Serum Institute
        11.9.1 Serum Institute Corporation Information
        11.9.2 Serum Institute Overview
        11.9.3 Serum Institute Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Serum Institute Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Serum Institute Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Hepatitis B Vaccines Industry Chain Analysis
    12.2 Hepatitis B Vaccines Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Hepatitis B Vaccines Production Mode & Process
    12.4 Hepatitis B Vaccines Sales and Marketing
        12.4.1 Hepatitis B Vaccines Sales Channels
        12.4.2 Hepatitis B Vaccines Distributors
    12.5 Hepatitis B Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Hepatitis B Vaccines Industry Trends
    13.2 Hepatitis B Vaccines Market Drivers
    13.3 Hepatitis B Vaccines Market Challenges
    13.4 Hepatitis B Vaccines Market Restraints
14 Key Findings in The Global Hepatitis B Vaccines Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Hepatitis B Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Yeast Derived
    Table 3. Major Manufacturers of CHO Derived
    Table 4. Global Hepatitis B Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Hepatitis B Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Hepatitis B Vaccines Sales by Region (2017-2022) & (M Doses)
    Table 7. Global Hepatitis B Vaccines Sales Market Share by Region (2017-2022)
    Table 8. Global Hepatitis B Vaccines Sales by Region (2023-2028) & (M Doses)
    Table 9. Global Hepatitis B Vaccines Sales Market Share by Region (2023-2028)
    Table 10. Global Hepatitis B Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Hepatitis B Vaccines Revenue Market Share by Region (2017-2022)
    Table 12. Global Hepatitis B Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Hepatitis B Vaccines Revenue Market Share by Region (2023-2028)
    Table 14. Global Hepatitis B Vaccines Sales by Manufacturers (2017-2022) & (M Doses)
    Table 15. Global Hepatitis B Vaccines Sales Share by Manufacturers (2017-2022)
    Table 16. Global Hepatitis B Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Hepatitis B Vaccines Revenue Share by Manufacturers (2017-2022)
    Table 18. Hepatitis B Vaccines Price by Manufacturers (2017-2022) &(USD/Doses)
    Table 19. Global Hepatitis B Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Hepatitis B Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Vaccines as of 2021)
    Table 21. Hepatitis B Vaccines Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Hepatitis B Vaccines Product Offered
    Table 23. Date of Manufacturers Enter into Hepatitis B Vaccines Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Hepatitis B Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 26. Global Hepatitis B Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 27. Global Hepatitis B Vaccines Sales Share by Type (2017-2022)
    Table 28. Global Hepatitis B Vaccines Sales Share by Type (2023-2028)
    Table 29. Global Hepatitis B Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Hepatitis B Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Hepatitis B Vaccines Revenue Share by Type (2017-2022)
    Table 32. Global Hepatitis B Vaccines Revenue Share by Type (2023-2028)
    Table 33. Hepatitis B Vaccines Price by Type (2017-2022) & (USD/Doses)
    Table 34. Global Hepatitis B Vaccines Price Forecast by Type (2023-2028) & (USD/Doses)
    Table 35. Global Hepatitis B Vaccines Sales by Application (2017-2022) & (M Doses)
    Table 36. Global Hepatitis B Vaccines Sales by Application (2023-2028) & (M Doses)
    Table 37. Global Hepatitis B Vaccines Sales Share by Application (2017-2022)
    Table 38. Global Hepatitis B Vaccines Sales Share by Application (2023-2028)
    Table 39. Global Hepatitis B Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Hepatitis B Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Hepatitis B Vaccines Revenue Share by Application (2017-2022)
    Table 42. Global Hepatitis B Vaccines Revenue Share by Application (2023-2028)
    Table 43. Hepatitis B Vaccines Price by Application (2017-2022) & (USD/Doses)
    Table 44. Global Hepatitis B Vaccines Price Forecast by Application (2023-2028) & (USD/Doses)
    Table 45. North America Hepatitis B Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 46. North America Hepatitis B Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 47. North America Hepatitis B Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Hepatitis B Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Hepatitis B Vaccines Sales by Application (2017-2022) & (M Doses)
    Table 50. North America Hepatitis B Vaccines Sales by Application (2023-2028) & (M Doses)
    Table 51. North America Hepatitis B Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Hepatitis B Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Hepatitis B Vaccines Sales by Country (2017-2022) & (M Doses)
    Table 54. North America Hepatitis B Vaccines Sales by Country (2023-2028) & (M Doses)
    Table 55. North America Hepatitis B Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Hepatitis B Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Hepatitis B Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 58. Europe Hepatitis B Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 59. Europe Hepatitis B Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Hepatitis B Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Hepatitis B Vaccines Sales by Application (2017-2022) & (M Doses)
    Table 62. Europe Hepatitis B Vaccines Sales by Application (2023-2028) & (M Doses)
    Table 63. Europe Hepatitis B Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Hepatitis B Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Hepatitis B Vaccines Sales by Country (2017-2022) & (M Doses)
    Table 66. Europe Hepatitis B Vaccines Sales by Country (2023-2028) & (M Doses)
    Table 67. Europe Hepatitis B Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Hepatitis B Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Hepatitis B Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 70. Asia Pacific Hepatitis B Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 71. Asia Pacific Hepatitis B Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Hepatitis B Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Hepatitis B Vaccines Sales by Application (2017-2022) & (M Doses)
    Table 74. Asia Pacific Hepatitis B Vaccines Sales by Application (2023-2028) & (M Doses)
    Table 75. Asia Pacific Hepatitis B Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Hepatitis B Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Hepatitis B Vaccines Sales by Region (2017-2022) & (M Doses)
    Table 78. Asia Pacific Hepatitis B Vaccines Sales by Region (2023-2028) & (M Doses)
    Table 79. Asia Pacific Hepatitis B Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Hepatitis B Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Hepatitis B Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 82. Latin America Hepatitis B Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 83. Latin America Hepatitis B Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Hepatitis B Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Hepatitis B Vaccines Sales by Application (2017-2022) & (M Doses)
    Table 86. Latin America Hepatitis B Vaccines Sales by Application (2023-2028) & (M Doses)
    Table 87. Latin America Hepatitis B Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Hepatitis B Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Hepatitis B Vaccines Sales by Country (2017-2022) & (M Doses)
    Table 90. Latin America Hepatitis B Vaccines Sales by Country (2023-2028) & (M Doses)
    Table 91. Latin America Hepatitis B Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Hepatitis B Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Hepatitis B Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 94. Middle East and Africa Hepatitis B Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 95. Middle East and Africa Hepatitis B Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Hepatitis B Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Hepatitis B Vaccines Sales by Application (2017-2022) & (M Doses)
    Table 98. Middle East and Africa Hepatitis B Vaccines Sales by Application (2023-2028) & (M Doses)
    Table 99. Middle East and Africa Hepatitis B Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Hepatitis B Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Hepatitis B Vaccines Sales by Country (2017-2022) & (M Doses)
    Table 102. Middle East and Africa Hepatitis B Vaccines Sales by Country (2023-2028) & (M Doses)
    Table 103. Middle East and Africa Hepatitis B Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Hepatitis B Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 105. GSK Corporation Information
    Table 106. GSK Description and Major Businesses
    Table 107. GSK Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 108. GSK Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. GSK Recent Developments
    Table 110. NCPC Corporation Information
    Table 111. NCPC Description and Major Businesses
    Table 112. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 113. NCPC Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. NCPC Recent Developments
    Table 115. Merck Corporation Information
    Table 116. Merck Description and Major Businesses
    Table 117. Merck Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 118. Merck Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Merck Recent Developments
    Table 120. Bio Kangtai Corporation Information
    Table 121. Bio Kangtai Description and Major Businesses
    Table 122. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 123. Bio Kangtai Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Bio Kangtai Recent Developments
    Table 125. Dynavax Corporation Information
    Table 126. Dynavax Description and Major Businesses
    Table 127. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 128. Dynavax Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Dynavax Recent Developments
    Table 130. Hissen Corporation Information
    Table 131. Hissen Description and Major Businesses
    Table 132. Hissen Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 133. Hissen Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Hissen Recent Developments
    Table 135. KM Biologics Corporation Information
    Table 136. KM Biologics Description and Major Businesses
    Table 137. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 138. KM Biologics Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. KM Biologics Recent Developments
    Table 140. LG Life Sciences Corporation Information
    Table 141. LG Life Sciences Description and Major Businesses
    Table 142. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 143. LG Life Sciences Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. LG Life Sciences Recent Developments
    Table 145. Serum Institute Corporation Information
    Table 146. Serum Institute Description and Major Businesses
    Table 147. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 148. Serum Institute Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Serum Institute Recent Developments
    Table 150. Key Raw Materials Lists
    Table 151. Raw Materials Key Suppliers Lists
    Table 152. Hepatitis B Vaccines Distributors List
    Table 153. Hepatitis B Vaccines Customers List
    Table 154. Hepatitis B Vaccines Market Trends
    Table 155. Hepatitis B Vaccines Market Drivers
    Table 156. Hepatitis B Vaccines Market Challenges
    Table 157. Hepatitis B Vaccines Market Restraints
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. Hepatitis B Vaccines Product Picture
    Figure 3. Global Hepatitis B Vaccines Market Share by Type in 2021 & 2028
    Figure 3. Yeast Derived Product Picture
    Figure 4. CHO Derived Product Picture
    Figure 5. Global Hepatitis B Vaccines Market Share by Application in 2021 & 2028
    Figure 6. Children
    Figure 7. Adult
    Figure 8. Hepatitis B Vaccines Report Years Considered
    Figure 9. Global Hepatitis B Vaccines Sales 2017-2028 (M Doses)
    Figure 10. Global Hepatitis B Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Hepatitis B Vaccines Revenue 2017-2028 (US$ Million)
    Figure 12. Global Hepatitis B Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Hepatitis B Vaccines Sales Market Share by Region (2017-2022)
    Figure 14. Global Hepatitis B Vaccines Sales Market Share by Region (2023-2028)
    Figure 15. North America Hepatitis B Vaccines Sales YoY (2017-2028) & (M Doses)
    Figure 16. North America Hepatitis B Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 17. Europe Hepatitis B Vaccines Sales YoY (2017-2028) & (M Doses)
    Figure 18. Europe Hepatitis B Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Asia-Pacific Hepatitis B Vaccines Sales YoY (2017-2028) & (M Doses)
    Figure 20. Asia-Pacific Hepatitis B Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Latin America Hepatitis B Vaccines Sales YoY (2017-2028) & (M Doses)
    Figure 22. Latin America Hepatitis B Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Middle East & Africa Hepatitis B Vaccines Sales YoY (2017-2028) & (M Doses)
    Figure 24. Middle East & Africa Hepatitis B Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. The Hepatitis B Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 26. The Top 5 and 10 Largest Manufacturers of Hepatitis B Vaccines in the World: Market Share by Hepatitis B Vaccines Revenue in 2021
    Figure 27. Global Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 28. Global Hepatitis B Vaccines Sales Market Share by Type (2017-2028)
    Figure 29. Global Hepatitis B Vaccines Revenue Market Share by Type (2017-2028)
    Figure 30. Global Hepatitis B Vaccines Sales Market Share by Application (2017-2028)
    Figure 31. Global Hepatitis B Vaccines Revenue Market Share by Application (2017-2028)
    Figure 32. North America Hepatitis B Vaccines Sales Market Share by Type (2017-2028)
    Figure 33. North America Hepatitis B Vaccines Revenue Market Share by Type (2017-2028)
    Figure 34. North America Hepatitis B Vaccines Sales Market Share by Application (2017-2028)
    Figure 35. North America Hepatitis B Vaccines Revenue Market Share by Application (2017-2028)
    Figure 36. North America Hepatitis B Vaccines Sales Share by Country (2017-2028)
    Figure 37. North America Hepatitis B Vaccines Revenue Share by Country (2017-2028)
    Figure 38. U.S. Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 39. Canada Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 40. Europe Hepatitis B Vaccines Sales Market Share by Type (2017-2028)
    Figure 41. Europe Hepatitis B Vaccines Revenue Market Share by Type (2017-2028)
    Figure 42. Europe Hepatitis B Vaccines Sales Market Share by Application (2017-2028)
    Figure 43. Europe Hepatitis B Vaccines Revenue Market Share by Application (2017-2028)
    Figure 44. Europe Hepatitis B Vaccines Sales Share by Country (2017-2028)
    Figure 45. Europe Hepatitis B Vaccines Revenue Share by Country (2017-2028)
    Figure 46. Germany Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 47. France Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 48. U.K. Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 49. Italy Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 50. Russia Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 51. Asia Pacific Hepatitis B Vaccines Sales Market Share by Type (2017-2028)
    Figure 52. Asia Pacific Hepatitis B Vaccines Revenue Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Hepatitis B Vaccines Sales Market Share by Application (2017-2028)
    Figure 54. Asia Pacific Hepatitis B Vaccines Revenue Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Hepatitis B Vaccines Sales Share by Region (2017-2028)
    Figure 56. Asia Pacific Hepatitis B Vaccines Revenue Share by Region (2017-2028)
    Figure 57. China Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 58. Japan Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 59. South Korea Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 60. India Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 61. Australia Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 62. Taiwan Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 63. Indonesia Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 64. Thailand Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 65. Malaysia Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 66. Philippines Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Hepatitis B Vaccines Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Hepatitis B Vaccines Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Hepatitis B Vaccines Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Hepatitis B Vaccines Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Hepatitis B Vaccines Sales Share by Country (2017-2028)
    Figure 72. Latin America Hepatitis B Vaccines Revenue Share by Country (2017-2028)
    Figure 73. Mexico Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Hepatitis B Vaccines Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Hepatitis B Vaccines Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Hepatitis B Vaccines Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Hepatitis B Vaccines Revenue Share by Country (2017-2028)
    Figure 82. Turkey Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 84. UAE Hepatitis B Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 85. Hepatitis B Vaccines Value Chain
    Figure 86. Hepatitis B Vaccines Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Frequently Asked Questions
Hepatitis B Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hepatitis B Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hepatitis B Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Epidural Catheter

Epidural Catheter market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More

Bulletproof Vehicle

Bulletproof Vehicle market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More

Curing Agent

Curing Agent market is segmented by Type and by Application. Players, stakeholders, and other par ... Read More